Influenza A M2 Protein Inhibitor class drugs

1 result
  • Gocovri

    (AMANTADINE)
    Adamas Pharma, LLC
    Usage: GOCOVRI® is indicated for treating dyskinesia in Parkinson’s disease patients on levodopa therapy, with or without additional dopaminergic medications, and as an adjunctive treatment to levodopa/carbidopa for patients experiencing “off” episodes.